Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.66 USD | -4.75% | -22.39% | -35.80% |
Jul. 03 | Barclays Downgrades Pacira BioSciences to Equalweight From Overweight, Adjusts Price Target to $25 From $38 | MT |
Jul. 02 | Pacira BioSciences Shares Tumble as FDA Approves Exparel Generic | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.80% | 1.01B | |
+54.07% | 809B | |
+38.95% | 621B | |
-7.05% | 351B | |
+15.44% | 319B | |
+5.72% | 289B | |
+14.21% | 238B | |
-0.45% | 221B | |
+14.58% | 218B | |
+7.42% | 166B |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Transcript : Pacira BioSciences, Inc., Q4 2023 Earnings Call, Feb 29, 2024